Drugs Controller General of India (DCGI) gave restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years, sources said.
Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID-19 Medicine 2-deoxy-D-glucose (2-DG) developed by Defence Research and Development Organization (DRDO).